| 000 | 01739 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517042054.0 | ||
| 264 | 0 | _c20171221 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1873-5010 | ||
| 024 | 7 |
_a10.1016/j.jcf.2015.06.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFox, Daniel J | |
| 245 | 0 | 0 |
_ad-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models. _h[electronic resource] |
| 260 |
_bJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society _c07 2016 |
||
| 300 |
_a518-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCystic Fibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 |
_aEar Diseases _xchemically induced |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 | _aEvoked Potentials, Auditory, Brain Stem |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 |
_aHair Cells, Auditory, Outer _xpathology |
| 650 | 0 | 4 |
_aMethionine _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aProtective Agents _xpharmacology |
| 650 | 0 | 4 |
_aTobramycin _xadministration & dosage |
| 700 | 1 | _aCooper, Morris D | |
| 700 | 1 | _aSpeil, Cristian A | |
| 700 | 1 | _aRoberts, Melissa H | |
| 700 | 1 | _aYanik, Susan C | |
| 700 | 1 | _aMeech, Robert P | |
| 700 | 1 | _aHargrove, Tim L | |
| 700 | 1 | _aVerhulst, Steven J | |
| 700 | 1 | _aRybak, Leonard P | |
| 700 | 1 | _aCampbell, Kathleen C M | |
| 773 | 0 |
_tJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society _gvol. 15 _gno. 4 _gp. 518-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcf.2015.06.005 _zAvailable from publisher's website |
| 999 |
_c25066158 _d25066158 |
||